missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Epo Monoclonal Antibody (148436)

Beschreibung
Reconstitute at 0.5 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
Erythropoietin (EPO) protein is a growth factor essential for the survival, proliferation, and differentiation of erythroid precursors. EPO is not responsible for early commitment to the lineage, and instead induces the final maturation of partially differentiated erythroid cells and the production of red cell-specific proteins, such as hemoglobin. The EPO receptor (EPOR) is present in higher levels on precursor cells, and expression diminishes with cell maturation.Hepatocytes are the main source of EPO in the fetus, followed by interstitial cells of the kidney after birth and through adulthood. EPO expression is upregulated during hypoxia, and low levels of transcription have also been detected in lung and brain tissue under these conditions. Recent data suggest that EPO may also play a role in the protection of neuronal tissue from damage and initiation of repair.
Spezifikation
Spezifikation
| Antigen | Epo |
| Anwendungen | ELISA, Neutralization |
| Klassifikation | Monoclonal |
| Klon | 148436 |
| Konzentration | 0.5 mg/mL |
| Konjugat | Unconjugated |
| Zusammensetzung | PBS with 5% trehalose and No Preservative |
| Gen | EPO |
| Gen-Zugriffsnummer | P07321 |
| Gen-Alias | EP; EPO; Epoetin; erythropoietin; MGC138142; MVCD2 |
| Mehr anzeigen |
Name des Produkts
Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.
Haben Sie Verbesserungsvorschläge?